There was no significant increase in GFP-PAO1 binding in the CF phenotype cells, even though they showed increased IL-8 and IL-6 responses following treatment with the broad spectrum neuraminidase of C. perfringens. The gene discussed is SMOX; the disease is cystic fibrosis.